Document is current
Any future updates will be listed below
-
Authors
Li, Dongshunyi
Velazquez, Jeremy J.
Ding, Jun
Hislop, Joshua
Ebrahimkhani, Mo R.
Bar-Joseph, Ziv
-
Funding
Funding for this research was provided by:
National Institutes of Health (1R01GM122096)
National Institutes of Health (OT2OD026682)
C3.ai DTI Research Award
National Institutes of Health (EB028532)
National Institutes of Health (HL141805)
National Institutes of Health (P30DK120531)
National Institute of Biomedical Imaging and Bioengineering (EB001026)
- License Information
-
More Information
Article History
Received: 20 December 2021
Accepted: 9 February 2022
First Online: 7 March 2022
Declarations
:
: Human induced pluripotent stem cell work performed in this study were approved by the University of Pittsburgh Human Stem Cell Research Oversight (hSCRO) committee.
: Not applicable.
: M.R.E and J.J.V. have a patent (WO2019237124) for the organoid technology used in this publication.
